tradingkey.logo

Intelligent Bio Solutions Inc

INBS
6.230USD
-0.090-1.42%
Close 02/06, 16:00ETQuotes delayed by 15 min
5.67MMarket Cap
LossP/E TTM

Intelligent Bio Solutions Inc

6.230
-0.090-1.42%

More Details of Intelligent Bio Solutions Inc Company

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.

Intelligent Bio Solutions Inc Info

Ticker SymbolINBS
Company nameIntelligent Bio Solutions Inc
IPO dateDec 23, 2020
CEOSimeonidis (Harry)
Number of employees16
Security typeOrdinary Share
Fiscal year-endDec 23
Address135 W 41St St,
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10036
Phone16467905756
Websitehttps://ibs.inc/
Ticker SymbolINBS
IPO dateDec 23, 2020
CEOSimeonidis (Harry)

Company Executives of Intelligent Bio Solutions Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
4.04K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
6.00
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
4.04K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
6.00
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United Kingdom
1.07M
96.14%
Rest of world
36.22K
3.26%
Americas
4.97K
0.45%
Australia
1.69K
0.15%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Fri, Jan 30
Updated: Fri, Jan 30
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Alyeska Investment Group, L.P.
5.54%
Adar1 Capital Management LLC
3.51%
Geode Capital Management, L.L.C.
0.48%
Sakiris (Spiro Kevin)
0.44%
Warberg Asset Management LLC
0.37%
Other
89.66%
Shareholders
Shareholders
Proportion
Alyeska Investment Group, L.P.
5.54%
Adar1 Capital Management LLC
3.51%
Geode Capital Management, L.L.C.
0.48%
Sakiris (Spiro Kevin)
0.44%
Warberg Asset Management LLC
0.37%
Other
89.66%
Shareholder Types
Shareholders
Proportion
Hedge Fund
9.41%
Individual Investor
0.78%
Investment Advisor
0.56%
Investment Advisor/Hedge Fund
0.48%
Research Firm
0.18%
Other
88.59%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
30
129.36K
10.64%
-1.19K
2025Q3
31
799.23K
8.80%
-446.50K
2025Q2
34
836.82K
11.26%
+144.79K
2025Q1
36
981.28K
14.20%
+429.65K
2024Q4
38
214.35K
3.16%
-507.92K
2024Q3
38
390.00K
7.80%
-236.97K
2024Q2
42
449.42K
76.55%
-259.12K
2024Q1
46
732.30K
88.07%
+589.21K
2023Q4
40
172.56K
98.30%
+79.74K
2023Q3
42
49.64K
11.24%
+14.21K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Alyeska Investment Group, L.P.
67.35K
5.54%
+5.96K
+9.71%
Sep 30, 2025
Adar1 Capital Management LLC
42.64K
3.51%
+42.64K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
5.89K
0.48%
+742.00
+14.42%
Sep 30, 2025
Sakiris (Spiro Kevin)
5.39K
0.44%
--
--
Sep 11, 2025
Warberg Asset Management LLC
4.47K
0.37%
+4.47K
--
Sep 30, 2025
Simeonidis (Harry)
4.04K
0.33%
--
--
Sep 11, 2025
LPL Financial LLC
2.50K
0.21%
+2.50K
--
Sep 30, 2025
Goldman Sachs & Company, Inc.
1.28K
0.11%
--
--
Sep 30, 2025
Citi Investment Research (US)
935.00
0.08%
+935.00
--
Sep 30, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Date
Ex-dividend Date
Type
Ratio
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
KeyAI